# Gait Analysis - Performance Report

## Overall Results

| Task | Our AUC | Baseline AUC | Improvement | Status |
|------|---------|--------------|-------------|--------|
| PD Screening (PD vs HS) | **0.963** | 0.821 | **+17.3%** | ‚úÖ |
| OA Screening (HOA vs HS) | **0.908** | 0.990 | **-8.3%** | ‚ö†Ô∏è |
| CVA Detection (CVA vs HS) | **0.986** | 0.950 | **+3.8%** | ‚úÖ |
| PD vs CVA Classification | **0.934** | 0.657 | **+42.1%** | üî• |

**Average Improvement (excluding OA)**: +21.1%

## Detailed Metrics

### PD Screening (PD vs HS)

| Metric | Our Model | Baseline | Improvement |
|--------|-----------|----------|-------------|
| ROC-AUC | 0.963 | 0.821 | +17.3% |
| Balanced Accuracy | 0.790 | 0.749 | +5.5% |
| Sensitivity | 0.595 | 0.739 | -19.5% |
| Specificity | 0.985 | 0.759 | +29.7% |

### OA Screening (HOA vs HS)

| Metric | Our Model | Baseline | Improvement |
|--------|-----------|----------|-------------|
| ROC-AUC | 0.908 | 0.990 | -8.3% |
| Balanced Accuracy | 0.786 | 0.948 | -17.1% |
| Sensitivity | 0.668 | 0.931 | -28.2% |
| Specificity | 0.904 | 0.965 | -6.3% |

### CVA Detection (CVA vs HS)

| Metric | Our Model | Baseline | Improvement |
|--------|-----------|----------|-------------|
| ROC-AUC | 0.986 | 0.950 | +3.8% |
| Balanced Accuracy | 0.936 | 0.883 | +6.1% |
| Sensitivity | 0.958 | 0.881 | +8.8% |
| Specificity | 0.914 | 0.884 | +3.4% |

### PD vs CVA Classification

| Metric | Our Model | Baseline | Improvement |
|--------|-----------|----------|-------------|
| ROC-AUC | 0.934 | 0.657 | +42.1% |
| Balanced Accuracy | 0.880 | 0.612 | +43.8% |
| Sensitivity | 0.942 | 0.606 | +55.5% |
| Specificity | 0.819 | 0.618 | +32.5% |

## Key Findings

1. **Best Performance**: PD vs CVA classification
   - +42.2% improvement in AUC
   - Excellent discrimination between two neurological disorders

2. **Concerning**: OA Screening performance drop
   - -8.3% decrease in AUC
   - Hypothesis: Baseline used HOA+KOA, we used HOA only
   - Action: Verify baseline methodology

3. **Consistent**: PD and CVA screening
   - Both show strong improvements (+17.3%, +3.8%)
   - Reliable detection of neurological gait disorders
